Dalpiciclib. Cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, Treatment of HR+/HER2-and HER2+advanced breast cancer

Wang, JR; Dong, XT; Ashby, CR; Chen, ZS; Zhang, YX

Zhang, YX (通讯作者)，Pathol Dept Weifang Peoples Hosp, Weifang, Peoples R China.;Chen, ZS (通讯作者)，St Johns Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Queens, NY 92591 USA.

DRUGS OF THE FUTURE, 2022; 47 (12): 867

Abstract

Breast cancer represents the highest number of new cases of cancer globally. Approximately 80% of patients diagnosed with breast cancer have hormone r......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索